
Join to view full profile
7 Portland Farms RdSte 2Scarborough, ME 04074
Phone+1 207-885-1400
Fax+1 207-885-1402
Dr. Drasby is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Medical Center2000 - 2002
Boston University Medical CenterResidency, Neurology, 1998 - 2002
Boston University Medical CenterInternship, Internal Medicine, 1997 - 1998
NYIT College Of Osteopathic MedicineClass of 1997
University of MaineMA, Literature, 1990 - 1993
Certifications & Licensure
ME State License 2001 - 2027
MA State License 1998 - 2003- American Board of Oseopathic PhysiciansMedicine
- American Board of Psychiatry and NeurologyMovement Disorders
Awards, Honors, & Recognition
- Maine Patients’ Choice Outstanding Physician of the Year, 2008, 2009, 2010, 2011,2012,2013,2014, 2014
- Honored Speaker AWARD Novartis Pharmaceuticals, 2004
- Instruction of junior residents and medical students in Neurology Boston University School of Medicine, 1998
Clinical Trials
Publications & Presentations
PubMed
- 294 citationsA Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of BenefitM. Flint Beal, David Oakes, Ira Shoulson, Claire Henchcliffe, Wendy R. Galpern
JAMA Neurology. 2014-05-01 - 84 citationsThe Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C. Latourelle, Mei Sun, Mark F. Lew, Oksana Suchowersky, Christine Klein
BMC Medicine. 2008-11-05 - 6 citationsHuntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD studyChristopher F. McNicoll, Jeanne C. Latourelle, Marcy E. MacDonald, Mark F. Lew, Oksana Suchowersky
Movement Disorders. 2008-08-15
Journal Articles
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease.C. Warren Olanow, M.D., Olivier Rascol, M.D., Ph.D., Robert Hauser, M.D., Paul D. Feigin, Ph.D., Joseph Jankovic, M.D., Anthony Lang, M.D., William Langston, M.D., E..., New England Journal of Medicine
- Detection of Cerebral Emboli with Transcranial Doppler Ultrasound.Babikian,V.L., Schwarze, J.J., Drasby E.J, Klingelhofer, J, Journal of Vascular Technology
Lectures
- What is Parkinson’s Disease.WCHS Television Program: “207” (Portland, Maine Local News & Events Forum)
- The Epidemiology, Pathophysiology, and Treatment of RLS.Maine Restless Legs Syndrome Support Group (Monthly Meeting)
- Newly Approved Treatments for the Dementia of Parkinson’s Disease.Novartis Sponsored Academic Lecture at Boston University Movement Disorders Conference
Other
- Polymorphisms and Expression in SIRT3 are associated with Parkinson disease: the GenePD Study.Nagle MW, BA1; Latourelle JC, DSc2; Lew MF, MD4; Klein C, MD5; Golbe LI, MD6; Mark MH, MD6; Growdon JH, MD7; Wooten GF, MD9; Watts RL, MD10; Litvan I, MD18; Drasby E...
- Alpha-synuclein and familial Parkinson's disease.Nathan Pankratz, PhD, William C. Nichols, PhD, Veronika E. Elsaesser, BS, Michael W. Pauciulo, MBA, Diane K. Marek, BS, Cheryl A. Halter, MS, Joanne Wojcieszek, MD, ...
- Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.N. Pankratz, PhD, D. K. Kissell, BS, M. W. Pauciulo, MBA, C. A. Halter, MS, A. Rudolph, PhD, R. F. Pfeiffer, MD, K. S. Marder, MD, T. Foroud, PhD, W. C. Nichols, PhD ...
Professional Memberships
- Member
- Member
- Member
- International Movement Disorder SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









